Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> AMGEN Latest News

MAY 09, 2016 - Yahoo! News

A Must Read - Share

Exclusive: Medivation succumbs to pressure to explore sale -sources

U.S. cancer drug maker Medivation Inc has decided to explore a sale following a $9.3 billion acquisition offer from France's Sanofi SA and interest from other companies, people familiar with the matter said on Monday. Pfizer Inc and Amgen Inc are among the companies that have signed non-disclosure agreements with Medivation, which allow them to obtain confidential information about the ...

Tags: Exclusive: Medivation succumbs to pressure to explore sale -sources,  Amgen Latest News

MAY 07, 2016 - Yahoo! News

A Must Read - Share

Independent group finds multiple myeloma drugs too costly in U.S

U.S. prices for newer multiple myeloma cancer treatments should be cut by as much as 94 percent to justify their value in terms of prolonging life, while there is not enough evidence to assess the benefit of some, according to an independent nonprofit organization that evaluates the effectiveness of medicines. The report has been criticized by some medical and patient ...

Tags: Independent group finds multiple myeloma drugs too costly in U.S,  Amgen Latest News

MAY 06, 2016 - Yahoo! News

A Must Read - Share

Independent group finds multiple myeloma drugs too costly in U.S.

U.S. prices for newer multiple myeloma cancer treatments should be cut by as much as 94 percent to justify their value in terms of prolonging life, while there is not enough evidence to assess the health benefit of some, according to an independent nonprofit organization that evaluates the effectiveness of medicines. The report has been criticized by some medical and ...

Tags: Independent group finds multiple myeloma drugs too costly in U.S.,  Amgen Latest News

MAY 06, 2016 - Yahoo! News

A Must Read - Share

Sanofi, Amgen cholesterol drugs win UK backing after price cuts

Two rival cholesterol-lowering injections from Sanofi and Amgen have been recommended by Britain's healthcare cost watchdog after the manufacturers offered special discounts to the country's state-run health service. Sanofi's Praluent, which was developed with Regeneron, and Amgen's Repatha are both so-called PCSK9 medicines that work in a different way to existing cholesterol fighters such as statins. The National Institute for ...

Tags: Sanofi, Amgen cholesterol drugs win UK backing after price cuts,  Amgen Latest News